Extra Strength Acetaminophen

Description

Acetaminophen is a non-opioid analgesic and antipyretic agent. Each tablet contains 500 mg of acetaminophen, which is utilized for the relief of pain and reduction of fever. The compound is characterized by its efficacy in managing mild to moderate pain and is commonly employed in various therapeutic settings.

Uses and Indications

This drug is indicated for the temporary relief of minor aches and pains associated with various conditions, including the common cold, headache, backache, minor pain of arthritis, toothache, muscular aches, and premenstrual and menstrual cramps. Additionally, it is indicated for the temporary reduction of fever.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

Adults and children aged 12 years and over are instructed to take 2 caplets every 6 hours as needed while symptoms persist. The maximum dosage should not exceed 6 caplets within a 24-hour period, unless otherwise directed by a healthcare professional. Additionally, the use of this medication should not extend beyond 10 days unless specifically advised by a doctor.

For children under 12 years of age, it is recommended to consult a healthcare professional for appropriate dosing guidance.

Contraindications

Use of this product is contraindicated in the following situations:

Patients should not use this product in conjunction with any other medication containing acetaminophen, whether prescription or nonprescription, due to the risk of acetaminophen overdose. If there is uncertainty regarding the presence of acetaminophen in other medications, consultation with a healthcare professional is advised.

Additionally, this product is contraindicated in individuals with a known allergy to acetaminophen or any of the inactive ingredients contained in the formulation, as this may lead to severe allergic reactions.

Warnings and Precautions

Patients should consult a healthcare professional prior to use if they have a history of liver disease. It is also advisable for individuals taking the anticoagulant warfarin to seek guidance from a doctor or pharmacist before initiating treatment.

In the event of worsening pain that persists beyond 10 days, or if fever intensifies or lasts more than 3 days, patients are advised to discontinue use and contact their healthcare provider. Additionally, the emergence of new symptoms or the presence of redness or swelling should prompt immediate consultation with a physician, as these may indicate a serious underlying condition.

Side Effects

Patients should be aware of potential serious adverse reactions that may indicate a serious condition. These include worsening pain that lasts more than 10 days, a fever that worsens or persists for more than 3 days, the occurrence of new symptoms, and the presence of redness or swelling.

Additionally, it is important for patients to consult a healthcare professional prior to use if they have liver disease. Patients who are taking the blood-thinning medication warfarin should also seek advice from a doctor or pharmacist before using this product.

Drug Interactions

Patients should consult a healthcare professional prior to using this medication if they are concurrently taking warfarin, a blood-thinning agent. The combination may increase the risk of bleeding due to potential pharmacodynamic interactions.

Additionally, this medication should not be used in conjunction with any other products containing acetaminophen, whether prescription or over-the-counter. Co-administration may lead to an increased risk of acetaminophen-related hepatotoxicity. If there is uncertainty regarding the presence of acetaminophen in other medications, patients are advised to seek guidance from a healthcare provider.

Packaging & NDC

Below are the non-prescription pack sizes of Extra Strength Acetaminophen (acetaminophen). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients under 12 years of age should consult a healthcare professional before use. For adolescents aged 12 years and older, the recommended dosage is 2 caplets every 6 hours as needed for symptom relief, with a maximum of 6 caplets in a 24-hour period. Treatment should not exceed 10 days unless directed by a healthcare provider.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. It is advisable to monitor these patients closely for any adverse effects or changes in efficacy.

Pregnancy

Pregnant patients and those who are breastfeeding should consult a healthcare professional prior to using this medication. The potential risks and benefits must be carefully weighed, as the effects on fetal outcomes and lactation are not fully established. It is essential for women of childbearing potential to seek medical advice to ensure safe use during pregnancy and lactation.

Lactation

Lactating mothers are advised to consult a health professional prior to using this medication. There is currently no available data regarding the excretion of this medication in human breast milk or its effects on breastfed infants. Therefore, caution is recommended when administering this medication to lactating individuals.

Renal Impairment

Renal impairment may necessitate dosage adjustments for patients. Those with reduced creatinine clearance should be closely monitored to ensure appropriate therapeutic levels and minimize the risk of adverse effects. Regular renal function tests are recommended to assess kidney status and guide treatment decisions. A reduced dose is advised for patients with moderate to severe renal impairment to account for altered pharmacokinetics. Additionally, special considerations should be taken into account for patients with end-stage renal disease, as their renal function significantly impacts drug metabolism and clearance.

Hepatic Impairment

Patients with hepatic impairment may require dosage adjustments due to compromised liver function. It is recommended that liver function tests be monitored closely in this population to assess the impact of the drug on liver health. Caution should be exercised when administering the drug to patients with liver dysfunction, ensuring that any potential risks are carefully weighed against the benefits of treatment.

Overdosage

In the absence of specific details regarding overdosage for this medication (SPL code 34088-5), healthcare professionals are advised to exercise caution and adhere to general principles of management in cases of suspected overdosage.

Recommended Actions In the event of an overdosage, it is essential to seek immediate medical attention. Healthcare providers should assess the patient's clinical status and consider the need for supportive care. Monitoring vital signs and providing symptomatic treatment may be necessary.

Potential Symptoms While specific symptoms of overdosage are not detailed, healthcare professionals should remain vigilant for any unusual or severe reactions that may arise. Symptoms can vary widely depending on the medication involved and the individual patient's response.

Management Procedures Management of overdosage should be tailored to the specific circumstances, including the amount ingested and the time since ingestion. Activated charcoal may be considered if the patient presents within a suitable timeframe and is alert. In cases of severe toxicity, advanced medical interventions may be required.

Healthcare professionals are encouraged to consult local poison control centers or toxicology experts for guidance on managing overdosage cases effectively.

Nonclinical Toxicology

If pregnant or breastfeeding, it is advised to consult a health professional prior to use. No specific non-teratogenic effects have been identified in the available data. Additionally, there are no detailed findings regarding nonclinical toxicology or animal pharmacology and toxicology provided in the current information.

Postmarketing Experience

Postmarketing experience has identified rare cases of severe skin reactions associated with acetaminophen use. Reported symptoms include skin reddening, blisters, and rash. These events were documented through voluntary reports and surveillance programs.

Patient Counseling

Healthcare providers should advise patients to keep this medication out of reach of children to prevent accidental ingestion. Patients should be informed not to use this product in conjunction with any other medications that contain acetaminophen, whether prescription or nonprescription. If patients are uncertain about the presence of acetaminophen in their other medications, they should be encouraged to consult with a doctor or pharmacist.

It is crucial to inform patients not to use this medication if they have a known allergy to acetaminophen or any of the inactive ingredients contained in the product. Patients should be instructed to discontinue use and seek medical advice if their pain worsens or persists for more than 10 days, if their fever worsens or lasts more than 3 days, or if they experience new symptoms. Additionally, patients should be made aware that the presence of redness or swelling may indicate a serious condition, and they should stop use and consult a doctor if these symptoms occur.

Patients with liver disease should be advised to consult a doctor before using this medication. Furthermore, those taking the blood-thinning medication warfarin should be encouraged to speak with a doctor or pharmacist prior to use to ensure safety and avoid potential interactions.

Storage and Handling

The product is supplied in packaging that includes specific NDC numbers. It should be stored at a temperature range of 20-25°C (68-77°F) to maintain its integrity and efficacy. Healthcare professionals are advised not to use the product if the carton has been opened or if the inner Safety Seal is broken or missing, as this may compromise the product's safety and effectiveness.

Additional Clinical Information

The medication is administered orally. Clinicians should advise patients who are pregnant or breastfeeding to consult a healthcare professional prior to use. No further information is available regarding laboratory tests, abuse potential, or postmarketing experiences.

Drug Information (PDF)

This file contains official product information for Extra Strength Acetaminophen, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)